MLSS
Price
$0.95
Change
+$0.02 (+2.15%)
Updated
Apr 24, 04:53 PM (EDT)
Capitalization
47.46M
20 days until earnings call
SRDX
Price
$29.41
Change
+$0.81 (+2.83%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
397.04M
5 days until earnings call
Ad is loading...

MLSS vs SRDX

Header iconMLSS vs SRDX Comparison
Open Charts MLSS vs SRDXBanner chart's image
Milestone Scientific
Price$0.95
Change+$0.02 (+2.15%)
Volume$150
Capitalization47.46M
Surmodics
Price$29.41
Change+$0.81 (+2.83%)
Volume$900
Capitalization397.04M
MLSS vs SRDX Comparison Chart
Loading...
MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLSS vs. SRDX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLSS is a StrongBuy and SRDX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (MLSS: $0.93 vs. SRDX: $28.68)
Brand notoriety: MLSS and SRDX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MLSS: 87% vs. SRDX: 24%
Market capitalization -- MLSS: $47.46M vs. SRDX: $397.04M
MLSS [@Medical Specialties] is valued at $47.46M. SRDX’s [@Medical Specialties] market capitalization is $397.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLSS’s FA Score shows that 0 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • MLSS’s FA Score: 0 green, 5 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLSS and SRDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLSS’s TA Score shows that 4 TA indicator(s) are bullish while SRDX’s TA Score has 5 bullish TA indicator(s).

  • MLSS’s TA Score: 4 bullish, 2 bearish.
  • SRDX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SRDX is a better buy in the short-term than MLSS.

Price Growth

MLSS (@Medical Specialties) experienced а +2.21% price change this week, while SRDX (@Medical Specialties) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

MLSS is expected to report earnings on Aug 19, 2025.

SRDX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRDX($397M) has a higher market cap than MLSS($47.5M). MLSS YTD gains are higher at: -3.646 vs. SRDX (-27.576). SRDX has higher annual earnings (EBITDA): 22.1M vs. MLSS (-6.99M). SRDX has more cash in the bank: 35.2M vs. MLSS (4.62M). MLSS has less debt than SRDX: MLSS (422K) vs SRDX (33.9M). SRDX has higher revenues than MLSS: SRDX (138M) vs MLSS (9.81M).
MLSSSRDXMLSS / SRDX
Capitalization47.5M397M12%
EBITDA-6.99M22.1M-32%
Gain YTD-3.646-27.57613%
P/E RatioN/A71.51-
Revenue9.81M138M7%
Total Cash4.62M35.2M13%
Total Debt422K33.9M1%
FUNDAMENTALS RATINGS
MLSS vs SRDX: Fundamental Ratings
MLSS
SRDX
OUTLOOK RATING
1..100
2866
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9591
PRICE GROWTH RATING
1..100
5262
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRDX's Valuation (91) in the Medical Specialties industry is in the same range as MLSS (95). This means that SRDX’s stock grew similarly to MLSS’s over the last 12 months.

SRDX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MLSS (100). This means that SRDX’s stock grew similarly to MLSS’s over the last 12 months.

SRDX's SMR Rating (91) in the Medical Specialties industry is in the same range as MLSS (95). This means that SRDX’s stock grew similarly to MLSS’s over the last 12 months.

MLSS's Price Growth Rating (52) in the Medical Specialties industry is in the same range as SRDX (62). This means that MLSS’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's P/E Growth Rating (92) in the Medical Specialties industry is in the same range as MLSS (100). This means that SRDX’s stock grew similarly to MLSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MLSSSRDX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
69%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TENB31.770.78
+2.52%
Tenable Holdings
MCRI77.661.63
+2.14%
Monarch Casino & Resort
ICMB3.120.06
+1.96%
Investcorp Credit Management BDC
BMO94.120.02
+0.02%
Bank of Montreal
HRTG19.07-0.28
-1.45%
Heritage Insurance Holdings

MLSS and

Correlation & Price change

A.I.dvisor tells us that MLSS and HBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and HBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+1.65%
HBIO - MLSS
30%
Poorly correlated
+0.97%
BLFS - MLSS
28%
Poorly correlated
+11.19%
SRDX - MLSS
26%
Poorly correlated
+0.24%
ANGO - MLSS
25%
Poorly correlated
+0.54%
ESTA - MLSS
25%
Poorly correlated
+3.89%
More